Vol.
-
No.
-
May 02, 2016May 02, 2016
Free
Trending Stories
- Caught in the crossfire: The critical threats facing cancer centers, research, and patient care
- Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - Trump’s tariffs will likely affect cancer drugs and devices—and may deepen drug shortages
